David Brennan
Director/Board Member chez INSMED INCORPORATED
Fortune : 2 M $ au 31/03/2024
Profil
David Richard Brennan est un homme d'affaires qui a été à la tête de 6 entreprises différentes. Il est président du conseil d'administration d'Alexion Pharmaceuticals, Inc. Il est également membre du conseil d'administration d'Insmed, Inc, du Gettysburg College et de la Philadelphia Orchestra Association. Dans le passé, M. Brennan a occupé les postes de directeur général et directeur exécutif chez AstraZeneca Plc ; directeur général chez AstraZeneca AB ; président et directeur général d'AstraZeneca LP et premier vice-président chargé de la planification et du développement des activités chez Astra Pharmaceuticals LP (qui sont toutes des filiales d'AstraZeneca Plc) ; directeur général dehibret International chez Merck & Co, Inc, membre de la Table ronde européenne des industriels, commissaire de la Commission britannique pour l'emploi et les compétences, président de la section du sud-est de la Pennsylvanie de l'American Heart Association (New York), président et trésorier de Pharmaceutical Research & Manufacturers of America, vice-président de la Fédération internationale de l'industrie du médicament et membre du conseil d'administration de la Fédération européenne des industries pharmaceutiques. M. Brennan a obtenu un diplôme de premier cycle au Gettysburg College.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
INSMED INCORPORATED
0,05% | 11/05/2023 | 80 876 ( 0,05% ) | 2 M $ | 31/03/2024 |
Postes actifs de David Brennan
Sociétés | Poste | Début |
---|---|---|
INSMED INCORPORATED | Director/Board Member | 29/05/2014 |
Gettysburg College | Director/Board Member | - |
Anciens postes connus de David Brennan
Sociétés | Poste | Fin |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Chief Executive Officer | 27/03/2017 |
ASTRAZENECA PLC | Chief Executive Officer | 01/06/2012 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Chief Executive Officer | 01/06/2012 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | President | 01/01/2012 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Chief Executive Officer | 01/01/2012 |
Formation de David Brennan
Gettysburg College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
RELX PLC | Commercial Services |
INSMED INCORPORATED | Health Technology |
Entreprise privées | 14 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Commercial Services |
European Round Table of Industrialists | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Astra Pharmaceuticals LP | |
UK Commission for Employment & Skills | Commercial Services |
American Heart Association (New York)
American Heart Association (New York) Miscellaneous Commercial ServicesCommercial Services Part of American Heart Association, Inc., American Heart Association (New York) provides public health educational services. The private company is based in New York, NY. | Commercial Services |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Health Technology |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Innocoll Holdings Plc
Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Innocoll Holdings Plc operates as a pharmaceutical company. It focuses on the development and commercialization of pharmaceutical technologies to meet healthcare challenges. The firm's late-stage product pipeline is focused on addressing patient needs for postsurgical pain management. The company was founded in 1997 and is headquartered in Athlone, Ireland. | Health Technology |